Here are nine key notes on major spine and orthopedic device companies.
Advanced Biologics announced the results of its most recent peer-reviewed data on the use of OsteoAMP for cervical spine fusions, showing that 80 percent of patients had evidence of fusions at six months, 98 percent of patients had evidence of fusions at 12 months, and 100 percent of patients had evidence of fusions at 18 months.
The Germany-based orthopedic implant coating company, DOT, plans to invest $4.5 million to establish DOT America in Columbia City, Ind.
FzioMed, a medical device manufacturer focusing on biomaterials, received notification from U.S. Food and Drug Administration that the Medical Device Dispute Resolution Panel will convene and make a decision on the approval of Oxiplex Gel on June 10.
IMPLANET announced the appointment of Brian T. Ennis as a new member of its board of directors.
K2M filed to raise between $141 million and $159 million through a recently announced initial public offering, by offering 8.8 million shares of common stock at a proposed price range of $16 to $18 a share.
Orthofix appointed David E. Ziegler as interim CFO.
SANUWAVE Health's CEO, Joseph Chiarelli, has left his post.
Stryker completed its previously announced acquisition of Berchtold Holding.
Memphis, Tenn.-based Wright Medical Group is planning a $4.28 million expansion to its existing facility in Arlington, Tenn.
More Articles on Devices:
Mazor Robotics 2013 Net Loss Shoots to $20M
Advancement in Lateral Spine Technology: Q&A with Vertebral Technologies, Inc. CEO Dr. Jeffrey Felt
EDGE Orthopaedics Receives FDA 510(k) Clearance for BITE Compression Screws